+145.8%
GOOG vs MRNA
+34.8%
+111.0%
-29.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.5% | +5.4% | -3.8% | +1.4% |
| 7D | 0.0% | -1.1% | +1.1% | +0.1% |
| 30D | -2.0% | +126.1% | -128.1% | -5.4% |
| 3M | -5.9% | +190.0% | -195.9% | -11.2% |
| 6M | +8.9% | +157.2% | -148.3% | +3.3% |
| YTD | +7.1% | +388.2% | -381.1% | -3.6% |
| 1Y | +39.7% | +467.0% | -427.4% | +23.7% |
| 3Y | +145.8% | +36.1% | +109.8% | +128.7% |
| All | +145.8% | +34.8% | +111.0% | +128.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling